Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2025)

Rapid Micro Biosystems' Gross Margin history spans 6 years, with the latest figure at 63.06% for Q3 2025.

  • For Q3 2025, Gross Margin rose 746.0% year-over-year to 63.06%; the TTM value through Sep 2025 reached 61.53%, up 1291.0%, while the annual FY2024 figure was 52.71%, 1187.0% up from the prior year.
  • Gross Margin for Q3 2025 was 63.06% at Rapid Micro Biosystems, up from 57.12% in the prior quarter.
  • Across five years, Gross Margin topped out at 63.71% in Q4 2024 and bottomed at 5.72% in Q4 2022.
  • The 5-year median for Gross Margin is 45.19% (2024), against an average of 41.72%.
  • The largest annual shift saw Gross Margin tumbled -3933bps in 2022 before it soared 4440bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 35.58% in 2021, then tumbled by -84bps to 5.72% in 2022, then soared by 777bps to 50.12% in 2023, then grew by 27bps to 63.71% in 2024, then dropped by -1bps to 63.06% in 2025.
  • Per Business Quant, the three most recent readings for RPID's Gross Margin are 63.06% (Q3 2025), 57.12% (Q2 2025), and 61.82% (Q1 2025).